Assessment of Collagen Type II Induced Arthritis in Mice by Whole Blood Chemiluminescence

References

• Lewis A. J., Carlson R. P., Chang J. Experimental models of inflammation. Handbook of inflammation 5: The pharmacology of inflammation, L. E. Glynn, J. C. Houk, G. Weissman. Elsevier, Amersterdam 1985; 371–397
   Google Scholar
• Boissier M. C., Feng X. Z., Carlioz A., Roudier R., Fornier C. Experimental autoimmune arthritis in mice. Homologous type II collagen is responsible for self‐perpetuating chronic polyarthritis. Ann. Rheum. Dis 1987; 46: 691–700
   PubMed Web of Science ®Google Scholar
• Wooley P. H. Collagen‐induced arthritis in the mouse. Meth. Enzymol 1988; 162: 361–373
   PubMed Web of Science ®Google Scholar
• Holmdahl R., Andersson M., Goldschmidt T. J., Gustafsson K., Jansson L., Mo J. A. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev 1990; 118: 193–232
   PubMed Web of Science ®Google Scholar
• Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen‐induced arthritis in mice. Major histocompatibility complex (I region) linkage and antibody response. J. Exp. Med 1981; 154: 688–700
   PubMed Web of Science ®Google Scholar
• Suzuki K., Ota H., Sasagawa S., Sakatani T., Fujikura T. Assay method for myeloperoxidase in human polymorpho‐nuclear leukocytes. Anal Biochem 1983; 132: 345–352
   PubMed Web of Science ®Google Scholar
• Schorlemmer H. U., Davies P., Hylton W., Gugig M., Allison A. C. The release of lysosomal acidic hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation. Br. J. Exp. Pathol 1977; 58: 315–326
   PubMedGoogle Scholar
• Pepys M. B., Baltz M., Comer K., Davies A. J.S., Doenhoff M. Serum amyloid P‐component is an acute phase reactant in the mouse. Nature 1979; 278: 259–261
   PubMed Web of Science ®Google Scholar
• Bell R. B., Steinman L. Trimolecular interactions in experimental autoimmune demyelinating disease and prospects for immunotherapy. Semin. Immunol 1991; 3: 237–245
   PubMedGoogle Scholar
• Charriere C. Immune mechanisms in autoimmune thyroiditis. Advances in Immunol 1989; 46: 263–334
   PubMed Web of Science ®Google Scholar
• Wacker W. B. Experimental allergic uvcitis. Investigations of retinal autoimmunity and the immunopathological responses evoked. Invest. Opthalmol. Vis. Sci 1991; 32: 3119–3128
   PubMed Web of Science ®Google Scholar
• Lindena J., Burkhardt H., Dwcngcr A. Mechanisms of nonopsonized zymosan‐induced and luminol‐enhanced chemiluminesccnce in whole blood and isolated phagocytes. J. Clin. Chem. Clin. Biochem 1987; 25: 765–778
   PubMedGoogle Scholar
• Kaever V., Robitzsch J. T., Stangel W., Schlcinkofer L., Resche K. Simultaneous detection of whole blood chemiluminescence in microtitre plates. Eur. J. Clin. Chem. Clin. Biochem 1992; 30: 209–216
   PubMedGoogle Scholar
• Wallaert B., Lassalle P., Fortin F., Acrts C., Bart F., Fournier E., Voisin C. Superoxide anion generation by alveolar inflammatory cells in simple pneumoconiosis and the progressive massive fibrosis of nonsmoking coal workers. Am. Rev. Respir. Dis 1990; 141: 129–133
   PubMed Web of Science ®Google Scholar
• Davies G. R., Simmonds N. J., Stevens T. R., Grandison A., Blake D. R., Rampton D. S. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992; 33: 1467–172
   PubMed Web of Science ®Google Scholar
• Simmonds N. J., Allen R. E., Stevens T. R., Van Someren R. N., Blake D. R., Rampton D. S. Chemiluminesccnce assay of mucosal reactive oxygen metabolities in inflammatory bowel disease. Gastroenterology 1992; 103: 186–196
   PubMed Web of Science ®Google Scholar
• Müller‐Peddinghaus, Wurl M. The amplified chemiluminescence test to characterize anti‐rheumatic drugs as oxygen radical scavengers. Biochem. Pharmacol 1987; 36: 1125–1132
   PubMed Web of Science ®Google Scholar
• Stocker R., Frei B. Endogenous antioxidant defences in human plasma. Oxidative stress. Oxidants and Antioxidants, H. Sies. Academic Press, London 1991; 213–245
   Google Scholar
• Miller E. J., Rhodes R. K. Preparation and characterization of the different types of collagen. Methods Enzymol 1982; 82: 33–64
   PubMed Web of Science ®Google Scholar
• Van Vollenhoven R. F., Thorbcckc G. J., Siskind G. W. Exposure of female mice to type II collagen reduces susceptibility to collagen‐induced arthritis in offspring. Eur. J. Immunol 1990; 20: 2149–2152
   PubMedGoogle Scholar
• Miesel R., Wcscr U. Antiinflammatory reactivity of Cu (I) thionein. Inflammation 1989; 14: 471–483
   Google Scholar
• Dresser D. W. An assay of adjuvanticity. Clin. Exp. Immunol 1968; 3: 877–888
   PubMedGoogle Scholar
• Beutler B., Cerami A. The biology of cachectin/TNF—a primary mediator of the host response. Annu. Rev. Immunol 1989; 7: 625–655
   PubMed Web of Science ®Google Scholar
• Cassatella M. A., Hartmann L., Perussia B., Trinchicri G. Tumor necrosis factor and immune interferon synergystically induce cytochromc b‐245 heavy chain gene expression and nicotinamide‐adenine dinucleotide phosphate hydrogcnase oxidase in human leukemic myeloid cells. J. Clin. Invest 1989; 83: 1570–1579
   PubMed Web of Science ®Google Scholar
• Ferrantc A. Activation of neutrophils by interlcukins‐1 and‐2 and tumor necrosis factor. Immunol. Ser 1992; 57: 417–436
   PubMedGoogle Scholar
• Arai K. I. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem 1990; 59: 783–836
   PubMed Web of Science ®Google Scholar
• Halliwell B. Drug antioxidant effects. A basis for drug selection?. Drugs 1991; 42: 569–605
   PubMed Web of Science ®Google Scholar
• Miesel R., Zuber M. Copper‐dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases. Inflammation 1993; 17: 283–294
   PubMed Web of Science ®Google Scholar
• Miesel R., Haas R. Reactivity of an active center analogue of Cu2Zn2 supcroxidc dismutasc in a murine model of acute and chronic inflammation. Inflammation 1993; 17: 595–611
   PubMed Web of Science ®Google Scholar
• Miesel R., Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation 1993; 17: 551–560
   PubMed Web of Science ®Google Scholar